Updated 2 hours ago
Last progress March 6, 2025 (11 months ago)
Updated 2 hours ago
Last progress March 3, 2025 (11 months ago)
Consolidated Appropriations Act, 2026
Updated 55 minutes ago
Last progress February 3, 2026 (2 days ago)
Extends and clarifies federal work on preventing and studying premature birth by renewing the prior research authorization for fiscal years 2025–2029, correcting earlier program language, and updating interagency roles. It requires the National Academies to carry out a comprehensive study of preterm birth—covering causes, costs, opportunities for earlier detection, and research priorities—and deliver a detailed report to HHS and Congress on a set schedule.
Amends section 3(e) of the PREEMIE Act (42 U.S.C. 247b–4f(e)) by replacing the phrase "fiscal years 2019 through 2023" with "fiscal years 2025 through 2029" to extend the referenced authorization period.
Makes a technical correction: in the PREEMIE Reauthorization Act of 2018 (Public Law 115–328), section 2 (in the matter preceding paragraph (1)) is amended by striking "Section 2" and inserting "Section 3." This correction is effective as if included in the 2018 Act.
Amends section 5(a) of the PREEMIE Reauthorization Act of 2018 by striking language that began "The Secretary of Health and Human Services, in collaboration with other departments, as appropriate, may establish" and inserting the phrase "PREEMIE Reauthorization Act of 2025." (Text is replaced as specified.)
Requires the Secretary of Health and Human Services to enter into arrangements with the National Academies of Sciences, Engineering, and Medicine for a study of premature births in the United States.
The National Academies must convene a committee of experts in maternal health not later than 30 days after the date of enactment to study premature births.
Primary impacts will be on pregnant and birthing people and newborns because the legislation seeks to strengthen the evidence base and federal coordination aimed at preventing preterm births and improving outcomes. Health care providers (obstetricians, maternal-fetal medicine specialists, neonatologists, midwives) and clinical systems may see future changes in screening, early-detection practices, and recommended interventions if the National Academies' findings prompt revised guidelines or funded programs. Academic institutions, research centers, and public-health agencies will be directly affected through the study requirement and potential shifts in research priorities and grant opportunities. Federal agencies involved in maternal and child health will have updated coordination responsibilities and may need to respond to the report's recommendations. Because the bill extends authorization but does not appropriate funds, the practical effects will depend on subsequent appropriations and agency implementation plans.
Referred to the House Committee on Energy and Commerce.
Last progress February 11, 2025 (11 months ago)
Introduced on February 11, 2025 by Robin L. Kelly
